NEWS
- FDA Approved PEGylated Drugs By 2025
- Beyond HER3-DXd: New Frontiers in HER3-Targeted Therapies for Lung Cancer
- 2024 FDA Approvals: 50 New Drugs
- siRNA Therapies for Alzheimer's Disease
- PROTAC Degraders in Clinical Trails: 2025 Update
- Dual-Payload ADCs: A Revolutionary Leap in Targeted Cancer Therapy
- Top Blockbuster Drugs to Watch for in 2025
- Lung Cancer Therapies: FDA Approvals in the First Half of 2025
- 2025 ADA Highlights: A New Era for GLP-1 Therapies in Obesity and Diabetes
- HZ-PEG-HZ (1K) Successfully Completed The FDA DMF Filing